Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
Andrew James WilsonEthan Troy-BarnesMaryam SubhanFiona ClarkRajeev GuptaAdele K FieldingPanagiotis KottaridisMarc R MansourJenny O'NionsElspeth M PayneNaina ChavdaRobert BakerKirsty ThomsonAsim KhwajaPublished in: British journal of haematology (2020)
Keyphrases
- acute myeloid leukemia
- coronavirus disease
- liver failure
- sars cov
- drug induced
- respiratory failure
- case report
- bone marrow
- dendritic cells
- tyrosine kinase
- early onset
- disease activity
- aortic dissection
- ulcerative colitis
- rheumatoid arthritis
- respiratory syndrome coronavirus
- systemic lupus erythematosus
- mesenchymal stem cells
- extracorporeal membrane oxygenation
- cell therapy
- wild type
- smoking cessation